{"transactions":[{"id":4633373,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Stock Option","published_at":"2026-10-02T01:30:11.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":39240,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001231589-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000021/primarydocument.xml","form_type":"4"}},{"id":4633372,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-10-02T01:30:11.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":160,"price":573.15,"value":91704.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":45172,"source":{"system":"sec-edgar","filing":"0001231589-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000021/primarydocument.xml","form_type":"4"}},{"id":4633371,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-10-02T01:30:11.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":823,"price":572.2492,"value":470961.0916,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $571.48 to $572.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45332,"source":{"system":"sec-edgar","filing":"0001231589-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000021/primarydocument.xml","form_type":"4"}},{"id":4633370,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-10-02T01:30:11.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":838,"price":570.8964,"value":478411.1832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $570.405 to $571.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46155,"source":{"system":"sec-edgar","filing":"0001231589-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000021/primarydocument.xml","form_type":"4"}},{"id":4633369,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-10-02T01:30:11.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":739,"price":569.148,"value":420600.372,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $568.94 to $569.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46993,"source":{"system":"sec-edgar","filing":"0001231589-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000021/primarydocument.xml","form_type":"4"}},{"id":4633368,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-10-02T01:30:11.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":720,"price":567.7615,"value":408788.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $567.495 to $568.175. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47732,"source":{"system":"sec-edgar","filing":"0001231589-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000021/primarydocument.xml","form_type":"4"}},{"id":4633367,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-10-02T01:30:11.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":400,"price":566.4062,"value":226562.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $566.405 to $566.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":48452,"source":{"system":"sec-edgar","filing":"0001231589-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000021/primarydocument.xml","form_type":"4"}},{"id":4633366,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-10-02T01:30:11.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":1480,"price":563.0904,"value":833373.792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $562.80 to $563.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":48852,"source":{"system":"sec-edgar","filing":"0001231589-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000021/primarydocument.xml","form_type":"4"}},{"id":4633365,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-10-02T01:30:11.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":780,"price":561.8705,"value":438258.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $561.70 to $562.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50332,"source":{"system":"sec-edgar","filing":"0001231589-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000021/primarydocument.xml","form_type":"4"}},{"id":4633364,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-10-02T01:30:11.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":1480,"price":560.191,"value":829082.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $560.00 to $560.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":51112,"source":{"system":"sec-edgar","filing":"0001231589-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000021/primarydocument.xml","form_type":"4"}},{"id":4633363,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-10-02T01:30:11.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":880,"price":558.3043,"value":491307.784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $558.30 to $558.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":52592,"source":{"system":"sec-edgar","filing":"0001231589-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000021/primarydocument.xml","form_type":"4"}},{"id":4633362,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-10-02T01:30:11.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":8300,"price":146.03,"value":1212049.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":53472,"source":{"system":"sec-edgar","filing":"0001231589-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000021/primarydocument.xml","form_type":"4"}},{"id":4623986,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Stock Option","published_at":"2026-09-18T20:40:41.000Z","date":"2026-09-17","kind":"exercise","planned":true,"acquired":false,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":47540,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001231589-26-000020","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000020/primarydocument.xml","form_type":"4"}},{"id":4623985,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-18T20:40:41.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":320,"price":501.5806,"value":160505.792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $501.53 to $501.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45172,"source":{"system":"sec-edgar","filing":"0001231589-26-000020","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000020/primarydocument.xml","form_type":"4"}},{"id":4623984,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-18T20:40:41.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":125,"price":500.8018,"value":62600.225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $500.485 to $501.095. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45492,"source":{"system":"sec-edgar","filing":"0001231589-26-000020","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000020/primarydocument.xml","form_type":"4"}},{"id":4623983,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-18T20:40:41.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":1160,"price":499.7515,"value":579711.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $499.355 to $500.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45617,"source":{"system":"sec-edgar","filing":"0001231589-26-000020","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000020/primarydocument.xml","form_type":"4"}},{"id":4623982,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-18T20:40:41.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":843,"price":498.737,"value":420435.291,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $498.3225 to $498.9375. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46777,"source":{"system":"sec-edgar","filing":"0001231589-26-000020","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000020/primarydocument.xml","form_type":"4"}},{"id":4623981,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-18T20:40:41.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":1400,"price":497.5434,"value":696560.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $497.12 to $498.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47620,"source":{"system":"sec-edgar","filing":"0001231589-26-000020","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000020/primarydocument.xml","form_type":"4"}},{"id":4623980,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-18T20:40:41.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":2873,"price":496.5758,"value":1426662.2734,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $496.12 to $497.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":49020,"source":{"system":"sec-edgar","filing":"0001231589-26-000020","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000020/primarydocument.xml","form_type":"4"}},{"id":4623979,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-18T20:40:41.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":1579,"price":495.967,"value":783131.893,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $495.09 to $496.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":51893,"source":{"system":"sec-edgar","filing":"0001231589-26-000020","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000020/primarydocument.xml","form_type":"4"}},{"id":4623978,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-18T20:40:41.000Z","date":"2026-09-17","kind":"exercise","planned":true,"acquired":true,"shares":8300,"price":146.03,"value":1212049.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":53472,"source":{"system":"sec-edgar","filing":"0001231589-26-000020","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000020/primarydocument.xml","form_type":"4"}},{"id":2563,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Stock Option","published_at":"2026-09-03T20:32:27.000Z","date":"2026-09-03","kind":"exercise","planned":true,"acquired":false,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":55840,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001231589-26-000019","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1231589/000123158926000019/primarydocument.xml","form_type":"4"}},{"id":2562,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-03T20:32:27.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":320,"price":490.885,"value":157083.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":45172,"source":{"system":"sec-edgar","filing":"0001231589-26-000019","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1231589/000123158926000019/primarydocument.xml","form_type":"4"}},{"id":2561,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-03T20:32:27.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":10,"price":488.32,"value":4883.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":45492,"source":{"system":"sec-edgar","filing":"0001231589-26-000019","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1231589/000123158926000019/primarydocument.xml","form_type":"4"}},{"id":2560,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-03T20:32:27.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":169,"price":487.3622,"value":82364.2118,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $487.06 to $487.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45502,"source":{"system":"sec-edgar","filing":"0001231589-26-000019","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1231589/000123158926000019/primarydocument.xml","form_type":"4"}},{"id":2559,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-03T20:32:27.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":598,"price":486.4682,"value":290907.9836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $486.025 to $487.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45671,"source":{"system":"sec-edgar","filing":"0001231589-26-000019","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1231589/000123158926000019/primarydocument.xml","form_type":"4"}},{"id":2558,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-03T20:32:27.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":954,"price":485.1228,"value":462807.1512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $484.81 to $485.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46269,"source":{"system":"sec-edgar","filing":"0001231589-26-000019","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1231589/000123158926000019/primarydocument.xml","form_type":"4"}},{"id":2557,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-03T20:32:27.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":200,"price":483.8494,"value":96769.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $483.42 to $484.115. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47223,"source":{"system":"sec-edgar","filing":"0001231589-26-000019","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1231589/000123158926000019/primarydocument.xml","form_type":"4"}},{"id":2556,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-03T20:32:27.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":160,"price":482.6625,"value":77226.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $482.38 to $482.875. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47423,"source":{"system":"sec-edgar","filing":"0001231589-26-000019","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1231589/000123158926000019/primarydocument.xml","form_type":"4"}},{"id":2555,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-03T20:32:27.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":1048,"price":481.917,"value":505049.016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $481.34 to $482.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47583,"source":{"system":"sec-edgar","filing":"0001231589-26-000019","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1231589/000123158926000019/primarydocument.xml","form_type":"4"}},{"id":2554,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-03T20:32:27.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":2360,"price":480.8613,"value":1134832.668,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $480.26 to $481.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":48631,"source":{"system":"sec-edgar","filing":"0001231589-26-000019","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1231589/000123158926000019/primarydocument.xml","form_type":"4"}},{"id":2553,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-03T20:32:27.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":936,"price":479.6575,"value":448959.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $479.24 to $480.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50991,"source":{"system":"sec-edgar","filing":"0001231589-26-000019","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1231589/000123158926000019/primarydocument.xml","form_type":"4"}},{"id":2552,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-03T20:32:27.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":1545,"price":478.9344,"value":739953.648,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $478.23 to $479.225. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":51927,"source":{"system":"sec-edgar","filing":"0001231589-26-000019","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231589/000123158926000019/primarydocument.xml","form_type":"4"}},{"id":2551,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-09-03T20:32:27.000Z","date":"2026-09-03","kind":"exercise","planned":true,"acquired":true,"shares":8300,"price":146.03,"value":1212049.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":53472,"source":{"system":"sec-edgar","filing":"0001231589-26-000019","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231589/000123158926000019/primarydocument.xml","form_type":"4"}},{"id":679250,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Stock Option","published_at":"2026-08-21T20:43:08.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":false,"shares":5610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":64140,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":5610},"source":{"system":"sec-edgar","filing":"0001231589-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000018/primarydocument.xml","form_type":"4"}},{"id":679249,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Stock Option","published_at":"2026-08-21T20:43:08.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":false,"shares":2690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":0,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":2690},"source":{"system":"sec-edgar","filing":"0001231589-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000018/primarydocument.xml","form_type":"4"}},{"id":679248,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-21T20:43:08.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":120,"price":527.21,"value":63265.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":45172,"source":{"system":"sec-edgar","filing":"0001231589-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000018/primarydocument.xml","form_type":"4"}},{"id":679247,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-21T20:43:08.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":400,"price":526.385,"value":210554.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $526.145 to $526.625. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45292,"source":{"system":"sec-edgar","filing":"0001231589-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000018/primarydocument.xml","form_type":"4"}},{"id":679246,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-21T20:43:08.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":940,"price":525.2504,"value":493735.376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $524.57 to $525.435. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45692,"source":{"system":"sec-edgar","filing":"0001231589-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000018/primarydocument.xml","form_type":"4"}},{"id":679245,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-21T20:43:08.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":192,"price":523.6897,"value":100548.4224,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $523.45 to $523.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46632,"source":{"system":"sec-edgar","filing":"0001231589-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000018/primarydocument.xml","form_type":"4"}},{"id":679244,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-21T20:43:08.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":850,"price":522.7838,"value":444366.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $522.43 to $523.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46824,"source":{"system":"sec-edgar","filing":"0001231589-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000018/primarydocument.xml","form_type":"4"}},{"id":679243,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-21T20:43:08.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":787,"price":522.0036,"value":410816.8332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $521.39 to $522.335. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47674,"source":{"system":"sec-edgar","filing":"0001231589-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000018/primarydocument.xml","form_type":"4"}},{"id":679242,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-21T20:43:08.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":1819,"price":521.0406,"value":947772.8514,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $520.36 to $521.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":48461,"source":{"system":"sec-edgar","filing":"0001231589-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000018/primarydocument.xml","form_type":"4"}},{"id":679241,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-21T20:43:08.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":502,"price":520.0331,"value":261056.6162,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $519.33 to $520.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50280,"source":{"system":"sec-edgar","filing":"0001231589-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000018/primarydocument.xml","form_type":"4"}},{"id":679240,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-21T20:43:08.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":2690,"price":524.15,"value":1409963.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":50782,"source":{"system":"sec-edgar","filing":"0001231589-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000018/primarydocument.xml","form_type":"4"}},{"id":679239,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-21T20:43:08.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":5610,"price":146.03,"value":819228.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":53472,"source":{"system":"sec-edgar","filing":"0001231589-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000018/primarydocument.xml","form_type":"4"}},{"id":679238,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-21T20:43:08.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":2690,"price":146.03,"value":392820.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":47862,"source":{"system":"sec-edgar","filing":"0001231589-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000018/primarydocument.xml","form_type":"4"}},{"id":694594,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Stock Option","published_at":"2026-08-06T20:35:19.000Z","date":"2026-08-06","kind":"exercise","planned":true,"acquired":false,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":72440,"derivative":{"exercise_price":146.03,"exercise_date":"2023-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001231589-26-000017","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000017/primarydocument.xml","form_type":"4"}},{"id":694593,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-06T20:35:19.000Z","date":"2026-08-06","kind":"sale","planned":true,"acquired":false,"shares":320,"price":522.395,"value":167166.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":45172,"source":{"system":"sec-edgar","filing":"0001231589-26-000017","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000017/primarydocument.xml","form_type":"4"}},{"id":694592,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-06T20:35:19.000Z","date":"2026-08-06","kind":"sale","planned":true,"acquired":false,"shares":1308,"price":521.4972,"value":682118.3376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $520.91 to $521.735. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45492,"source":{"system":"sec-edgar","filing":"0001231589-26-000017","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000017/primarydocument.xml","form_type":"4"}},{"id":694591,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-06T20:35:19.000Z","date":"2026-08-06","kind":"sale","planned":true,"acquired":false,"shares":360,"price":518.8231,"value":186776.316,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $518.735 to $519.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46800,"source":{"system":"sec-edgar","filing":"0001231589-26-000017","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000017/primarydocument.xml","form_type":"4"}},{"id":694590,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-06T20:35:19.000Z","date":"2026-08-06","kind":"sale","planned":true,"acquired":false,"shares":780,"price":517.9411,"value":403994.058,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $517.53 to $518.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47160,"source":{"system":"sec-edgar","filing":"0001231589-26-000017","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000017/primarydocument.xml","form_type":"4"}},{"id":694589,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-06T20:35:19.000Z","date":"2026-08-06","kind":"sale","planned":true,"acquired":false,"shares":1617,"price":516.9257,"value":835868.8569,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $516.52 to $517.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47940,"source":{"system":"sec-edgar","filing":"0001231589-26-000017","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000017/primarydocument.xml","form_type":"4"}},{"id":694588,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-06T20:35:19.000Z","date":"2026-08-06","kind":"sale","planned":true,"acquired":false,"shares":1360,"price":515.9303,"value":701665.208,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $515.50 to $516.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":49557,"source":{"system":"sec-edgar","filing":"0001231589-26-000017","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000017/primarydocument.xml","form_type":"4"}},{"id":694587,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-06T20:35:19.000Z","date":"2026-08-06","kind":"sale","planned":true,"acquired":false,"shares":1795,"price":514.8223,"value":924106.0285,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $514.47 to $515.335. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50917,"source":{"system":"sec-edgar","filing":"0001231589-26-000017","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000017/primarydocument.xml","form_type":"4"}},{"id":694586,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-06T20:35:19.000Z","date":"2026-08-06","kind":"sale","planned":true,"acquired":false,"shares":760,"price":512.9174,"value":389817.224,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $512.67 to $513.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":52712,"source":{"system":"sec-edgar","filing":"0001231589-26-000017","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000017/primarydocument.xml","form_type":"4"}},{"id":694585,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-08-06T20:35:19.000Z","date":"2026-08-06","kind":"exercise","planned":true,"acquired":true,"shares":8300,"price":146.03,"value":1212049.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":53472,"source":{"system":"sec-edgar","filing":"0001231589-26-000017","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000017/primarydocument.xml","form_type":"4"}},{"id":708368,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Stock Option","published_at":"2026-07-16T20:30:21.000Z","date":"2026-07-16","kind":"exercise","planned":true,"acquired":false,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":80740,"derivative":{"exercise_price":146.03,"exercise_date":"2023-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001231589-26-000016","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000016/primarydocument.xml","form_type":"4"}},{"id":708367,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-16T20:30:21.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":80,"price":536.8526,"value":42948.208,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $536.75 to $536.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45172,"source":{"system":"sec-edgar","filing":"0001231589-26-000016","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000016/primarydocument.xml","form_type":"4"}},{"id":708366,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-16T20:30:21.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":1519,"price":534.9891,"value":812648.4429,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $534.56 to $535.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45252,"source":{"system":"sec-edgar","filing":"0001231589-26-000016","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000016/primarydocument.xml","form_type":"4"}},{"id":708365,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-16T20:30:21.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":1041,"price":535.8798,"value":557850.8718,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $535.565 to $536.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46771,"source":{"system":"sec-edgar","filing":"0001231589-26-000016","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000016/primarydocument.xml","form_type":"4"}},{"id":708364,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-16T20:30:21.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":3279,"price":534.2114,"value":1751679.1806,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $533.56 to $534.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47812,"source":{"system":"sec-edgar","filing":"0001231589-26-000016","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000016/primarydocument.xml","form_type":"4"}},{"id":708363,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-16T20:30:21.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":800,"price":532.9394,"value":426351.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $532.51 to $533.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":51091,"source":{"system":"sec-edgar","filing":"0001231589-26-000016","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000016/primarydocument.xml","form_type":"4"}},{"id":708362,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-16T20:30:21.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":861,"price":531.9692,"value":458025.4812,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $531.50 to $532.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":51891,"source":{"system":"sec-edgar","filing":"0001231589-26-000016","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000016/primarydocument.xml","form_type":"4"}},{"id":708361,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-16T20:30:21.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":120,"price":529.81,"value":63577.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":52752,"source":{"system":"sec-edgar","filing":"0001231589-26-000016","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000016/primarydocument.xml","form_type":"4"}},{"id":708360,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-16T20:30:21.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":600,"price":527.595,"value":316557.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":52872,"source":{"system":"sec-edgar","filing":"0001231589-26-000016","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000016/primarydocument.xml","form_type":"4"}},{"id":708359,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-16T20:30:21.000Z","date":"2026-07-16","kind":"exercise","planned":true,"acquired":true,"shares":8300,"price":146.03,"value":1212049.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":53472,"source":{"system":"sec-edgar","filing":"0001231589-26-000016","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000016/primarydocument.xml","form_type":"4"}},{"id":719120,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Stock Option","published_at":"2026-07-02T20:32:05.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":false,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":89040,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001231589-26-000015","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000015/primarydocument.xml","form_type":"4"}},{"id":719119,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-02T20:32:05.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":225,"price":556.3589,"value":125180.7525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $556.19 to $556.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45172,"source":{"system":"sec-edgar","filing":"0001231589-26-000015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000015/primarydocument.xml","form_type":"4"}},{"id":719118,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-02T20:32:05.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":990,"price":555.8257,"value":550267.443,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $555.16 to $556.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45397,"source":{"system":"sec-edgar","filing":"0001231589-26-000015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000015/primarydocument.xml","form_type":"4"}},{"id":719117,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-02T20:32:05.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":299,"price":554.4454,"value":165779.1746,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $554.13 to $555.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46387,"source":{"system":"sec-edgar","filing":"0001231589-26-000015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000015/primarydocument.xml","form_type":"4"}},{"id":719116,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-02T20:32:05.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":2201,"price":553.5167,"value":1218290.2567,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $553.13 to $554.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46686,"source":{"system":"sec-edgar","filing":"0001231589-26-000015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000015/primarydocument.xml","form_type":"4"}},{"id":719115,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-02T20:32:05.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":1818,"price":552.6068,"value":1004639.1624,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $552.12 to $553.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":48887,"source":{"system":"sec-edgar","filing":"0001231589-26-000015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000015/primarydocument.xml","form_type":"4"}},{"id":719114,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-02T20:32:05.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":1467,"price":551.2961,"value":808751.3787,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $550.85 to $551.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50705,"source":{"system":"sec-edgar","filing":"0001231589-26-000015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000015/primarydocument.xml","form_type":"4"}},{"id":719113,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-02T20:32:05.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":384,"price":550.0235,"value":211209.024,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $549.535 to $550.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":52172,"source":{"system":"sec-edgar","filing":"0001231589-26-000015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000015/primarydocument.xml","form_type":"4"}},{"id":719112,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-02T20:32:05.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":258,"price":548.7314,"value":141572.7012,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $548.47 to $549.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":52556,"source":{"system":"sec-edgar","filing":"0001231589-26-000015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000015/primarydocument.xml","form_type":"4"}},{"id":719111,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-02T20:32:05.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":658,"price":548.0012,"value":360584.7896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $547.45 to $548.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":52814,"source":{"system":"sec-edgar","filing":"0001231589-26-000015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000015/primarydocument.xml","form_type":"4"}},{"id":719110,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-07-02T20:32:05.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":true,"shares":8300,"price":146.03,"value":1212049.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":53472,"source":{"system":"sec-edgar","filing":"0001231589-26-000015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000015/primarydocument.xml","form_type":"4"}},{"id":732658,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Stock Option","published_at":"2026-06-18T20:31:08.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":false,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":97340,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001231589-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000014/primarydocument.xml","form_type":"4"}},{"id":732657,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-18T20:31:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":400,"price":551.74,"value":220696.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $551.50 to $551.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45172,"source":{"system":"sec-edgar","filing":"0001231589-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000014/primarydocument.xml","form_type":"4"}},{"id":732656,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-18T20:31:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":496,"price":548.9125,"value":272260.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $548.415 to $549.165. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45572,"source":{"system":"sec-edgar","filing":"0001231589-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000014/primarydocument.xml","form_type":"4"}},{"id":732655,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-18T20:31:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":881,"price":547.6458,"value":482475.9498,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $547.13 to $547.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46068,"source":{"system":"sec-edgar","filing":"0001231589-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000014/primarydocument.xml","form_type":"4"}},{"id":732654,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-18T20:31:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":157,"price":546.1458,"value":85744.8906,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $545.88 to $546.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46949,"source":{"system":"sec-edgar","filing":"0001231589-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000014/primarydocument.xml","form_type":"4"}},{"id":732653,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-18T20:31:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":480,"price":544.2631,"value":261246.288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $544.215 to $545.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47106,"source":{"system":"sec-edgar","filing":"0001231589-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000014/primarydocument.xml","form_type":"4"}},{"id":732652,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-18T20:31:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":160,"price":541.95,"value":86712.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":47586,"source":{"system":"sec-edgar","filing":"0001231589-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000014/primarydocument.xml","form_type":"4"}},{"id":732651,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-18T20:31:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":950,"price":541.255,"value":514192.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $540.87 to $541.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47746,"source":{"system":"sec-edgar","filing":"0001231589-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000014/primarydocument.xml","form_type":"4"}},{"id":732650,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-18T20:31:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":798,"price":540.2487,"value":431118.4626,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $539.865 to $540.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":48696,"source":{"system":"sec-edgar","filing":"0001231589-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000014/primarydocument.xml","form_type":"4"}},{"id":732649,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-18T20:31:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":1305,"price":539.4154,"value":703937.097,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $538.86 to $539.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":49494,"source":{"system":"sec-edgar","filing":"0001231589-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000014/primarydocument.xml","form_type":"4"}},{"id":732648,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-18T20:31:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":958,"price":538.0277,"value":515430.5366,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $537.58 to $538.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50799,"source":{"system":"sec-edgar","filing":"0001231589-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000014/primarydocument.xml","form_type":"4"}},{"id":732647,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-18T20:31:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":1715,"price":537.0418,"value":921026.687,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $536.495 to $537.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":51757,"source":{"system":"sec-edgar","filing":"0001231589-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000014/primarydocument.xml","form_type":"4"}},{"id":732646,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-18T20:31:08.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":true,"shares":8300,"price":146.03,"value":1212049.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":53472,"source":{"system":"sec-edgar","filing":"0001231589-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000014/primarydocument.xml","form_type":"4"}},{"id":750111,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Stock Option","published_at":"2026-06-04T21:30:37.000Z","date":"2026-06-04","kind":"exercise","planned":true,"acquired":false,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":105640,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001231589-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000013/primarydocument.xml","form_type":"4"}},{"id":750110,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-04T21:30:37.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":1250,"price":549.47,"value":686837.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":45172,"source":{"system":"sec-edgar","filing":"0001231589-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000013/primarydocument.xml","form_type":"4"}},{"id":750109,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-04T21:30:37.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":593,"price":549.4948,"value":325850.4164,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $549.12 to $549.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46422,"source":{"system":"sec-edgar","filing":"0001231589-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000013/primarydocument.xml","form_type":"4"}},{"id":750108,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-04T21:30:37.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":1481,"price":548.425,"value":812217.425,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $547.90 to $548.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47015,"source":{"system":"sec-edgar","filing":"0001231589-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000013/primarydocument.xml","form_type":"4"}},{"id":750107,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-04T21:30:37.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":935,"price":547.1108,"value":511548.598,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $546.80 to $547.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":48496,"source":{"system":"sec-edgar","filing":"0001231589-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000013/primarydocument.xml","form_type":"4"}},{"id":750106,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-04T21:30:37.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":2627,"price":546.4178,"value":1435439.5606,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $545.80 to $546.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":49431,"source":{"system":"sec-edgar","filing":"0001231589-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000013/primarydocument.xml","form_type":"4"}},{"id":750105,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-04T21:30:37.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":374,"price":545.2671,"value":203929.8954,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $544.795 to $545.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":52058,"source":{"system":"sec-edgar","filing":"0001231589-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000013/primarydocument.xml","form_type":"4"}},{"id":750104,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-04T21:30:37.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":840,"price":543.8893,"value":456867.012,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $543.59 to $544.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":52432,"source":{"system":"sec-edgar","filing":"0001231589-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000013/primarydocument.xml","form_type":"4"}},{"id":750103,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":1889,"kind":"person","name":"MAHON PAUL A","position":1,"cik":"0001231589","reported_name":"MAHON PAUL A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-04T21:30:37.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":200,"price":539.76,"value":107952.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025."}],"balance_after":53272,"source":{"system":"sec-edgar","filing":"0001231589-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000123158926000013/primarydocument.xml","form_type":"4"}}],"next_cursor":"2026-06-04T21:30:37.000000Z,750103"}